Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China · Delayed Price · Currency is CNY 44.60
+1.63 (3.79%)
Mar 27, 2026, 4:00 PM EDT
Shanghai OPM Biosciences Market Cap
Shanghai OPM Biosciences has a market cap or net worth of 5.8 billion as of March 30, 2026. Its market cap has increased by 19.70% in one year.
Market Cap
5.80B
Enterprise Value
4.49B
Revenue
354.91M
Ranking
n/a
PE Ratio
120.54
Stock Price
44.60
Market Cap Chart
Since September 2, 2022, Shanghai OPM Biosciences's market cap has decreased from 10.43B to 5.80B, a decrease of -44.40%. That is a compound annual growth rate of -15.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 5.80B | 3.99% |
| Dec 31, 2025 | 5.58B | 34.44% |
| Dec 31, 2024 | 4.15B | -34.49% |
| Dec 29, 2023 | 6.33B | -25.16% |
| Dec 30, 2022 | 8.46B | -18.89% |
| Sep 2, 2022 | 10.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Weiguang Biological Products | 6.24B |
| Xiangxue Pharmaceutical | 6.23B |
| GemPharmatech | 6.00B |
| Lifecome Biochemistry | 5.92B |
| R&G PharmaStudies | 5.91B |
| Beijing Konruns Pharmaceutical | 5.85B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.77B |
| Novogene | 5.59B |